| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1.2 | 1.7 | 1.6 |
| Other income | 0.1 | 0.2 | 0.1 |
| Total income | 1.4 | 1.9 | 1.6 |
| Profit before exceptional items & tax | 0.1 | 0.2 | 0.2 |
| Exceptional items | 2.8 | 0.0 | 0.0 |
| Profit before tax | 2.9 | 0.2 | 0.2 |
| Net profit | 2.4 | 0.2 | 0.1 |
| Operating margin | 207.1% | 10.5% | 12.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +2300.00% |
|---|---|
| Net profit, quarter on quarter | +1100.00% |
| Revenue, year on year | -25.00% |
BSE results filing, NSE: COLINZ. Figures extracted from the filing.
Colinz Laboratories Ltd: key numbers
- Share price
- ₹71.80
- Market cap
- ₹18.09 Cr
- Revenue (annual)
- ₹6.14 Cr
- Net profit (annual)
- ₹0.51 Cr
- P/E (TTM)
- 6.5×Sector 47.4×
- Promoter holding
- 50.60%-15.40% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colinz Laboratories Ltd
All →Colinz Laboratories Annual General Meeting
Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.
Colinz Laboratories Open Offer: ₹3.54 Cr
Colinz Laboratories Ltd issued a Post Offer Advertisement for an Open Offer. The offer closed with only 6 shares tendered out of a proposed 6,54,966 shares.
- Value
- ₹3.54 Cr
Colinz Laboratories Annual Report
Colinz Laboratories Limited has submitted its 40th Annual Report for the financial year 2025-26. The report includes notice for the Annual General Meeting scheduled for September 22, 2026.
Colinz Laboratories Annual General Meeting
Colinz Laboratories Ltd has issued the notice for its 40th Annual General Meeting scheduled for September 22, 2026. The agenda includes director re-appointments and auditor report adoption.
Colinz Laboratories Open Offer: ₹3.54 Cr
Saffron Capital Advisors filed a reminder advertisement for the open offer of Colinz Laboratories. The offer seeks to acquire up to 26% stake for ₹3.54 Crore.
- Value
- ₹3.54 Cr
Colinz Laboratories Open Offer: ₹3.54 Cr
The acquirers made an Open Offer to buy up to 6,54,966 shares of Colinz Laboratories Limited at ₹54 per share. This offer totals ₹3.54 Crore.
- Value
- ₹3.54 Cr